Hofseth Biocare ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Hofseth Biocare says new mixing technology and enzymes show promising results
Hofseth Biocare ASA:Says has been working with the development of more efficient mixing systems and enzymes for use in the production facility in Midsund.Says the results show a considerable rationalization of the enzymatic hydrolysis process for production of fresh salmon oil, marine proteins and marine calcium.Says tests were conducted in Germany and showed reduction of hydrolysis time compared to the time today.Finds results promising and will continue in 2014 to plan implementation of the new technology and enzymes at the Midsund plant.Says the tests also show that the batch sizes may be increased somewhat in volume.
Latest Developments for Hofseth Biocare ASA
- Share this
- Digg this